WHAT WE OFFER
The unique positioning of InFocus Clinical, as founded by USRetina, ensures rapid integration of your protocol with KOLs, key enrolling sites and, ultimately, the greatest possible exposure of your product throughout development.The InFocus Scientific Advisory Board is comprised of the most proven and respected retina specialists. The fact InFocus is not just therapeutically aligned but focused, with proprietary and unprecedented staff training, ensures our staff are the most knowledgeable and your product is developed with superior efficiency and commitment.
With all of these elements, InFocus Clinical assures an unparalleled quality, integrity, flexibility, knowledge, experience, insight and responsiveness to the needs of a protocol or drug development program large or small.
Led by a passionate visionary and proven leader
Brad founded PharmaMed Research in 2001 prior to co-founding InFocus Clinical in partnership with USRetina – the leading alliance of retina specialists. A 2012 PharmaVoice 100 recipient with a 20 year history of leadership in development of landmark products including Tamiflu, Pegasys, Provenge and many others, Brad has a proven ability to connect with all levels of a clinical development program.
Recent News & Upcoming Events
Stay up to date with InFocus Clinical news or join us at an upcoming event
- The Challenge An InFocus Clinical Research partner facing a long clinical development pathway of a sensitive, costly, biotechnology product was concerned about a multitude of parameters […]
- The Challenge An InFocus Clinical Research partner with a single product, limited resources and anxious investors was faced with an unforeseen protocol delay, requiring FDA interactions […]
- The Challenge Two sponsors approached InFocus Clinical Research with similar, critical pathway Phase I clinical trials struggling to meet enrollment timelines and needing six to eight […]